PLOS Global Public Health (Jan 2023)

Trends in treatment-seeking for fever in children under five years old in 151 countries from 1990 to 2020.

  • Michele Nguyen,
  • Paulina A Dzianach,
  • Paul E C W Castle,
  • Susan F Rumisha,
  • Jennifer A Rozier,
  • Joseph R Harris,
  • Harry S Gibson,
  • Katherine A Twohig,
  • Camilo A Vargas-Ruiz,
  • Donal Bisanzio,
  • Ewan Cameron,
  • Daniel J Weiss,
  • Samir Bhatt,
  • Peter W Gething,
  • Katherine E Battle

DOI
https://doi.org/10.1371/journal.pgph.0002134
Journal volume & issue
Vol. 3, no. 8
p. e0002134

Abstract

Read online

Access to medical treatment for fever is essential to prevent morbidity and mortality in individuals and to prevent transmission of communicable febrile illness in communities. Quantification of the rates at which treatment is accessed is critical for health system planning and a prerequisite for disease burden estimates. In this study, national data on the proportion of children under five years old with fever who were taken for medical treatment were collected from all available countries in Africa, Latin America, and Asia (n = 91). We used generalised additive mixed models to estimate 30-year trends in the treatment-seeking rates across the majority of countries in these regions (n = 151). Our results show that the proportions of febrile children brought for medical treatment increased steadily over the last 30 years, with the greatest increases occurring in areas where rates had originally been lowest, which includes Latin America and Caribbean, North Africa and the Middle East (51 and 50% increase, respectively), and Sub-Saharan Africa (23% increase). Overall, the aggregated and population-weighted estimate of children with fever taken for treatment at any type of facility rose from 61% (59-64 95% CI) in 1990 to 71% (69-72 95% CI) in 2020. The overall population-weighted average for fraction of treatment in the public sector was largely unchanged during the study period: 49% (42-58 95% CI) sought care at public facilities in 1990 and 47% (44-52 95% CI) in 2020. Overall, the findings indicate that improvements in access to care have been made where they were most needed, but that despite rapid initial gains, progress can plateau without substantial investment. In 2020 there remained significant gaps in care utilisation that must be factored in when developing control strategies and deriving disease burden estimates.